Overview

Pharmacokinetics-pharmacodynamics and Safety of Dexmedetomidine in Children

Status:
Completed
Trial end date:
2019-11-14
Target enrollment:
Participant gender:
Summary
This study evaluates pharmacokinetics and pharmacodynamics of dexmedetomidine for children under sedation at intensive care unit after surgery. Patients will receive dexmedetomidine intravenously for 50 minutes after surgery as as sedation drug.
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Ministry of Food and Drug Safety, Korea
Treatments:
Dexmedetomidine